- This event has passed.
Innovative Medicines Initiative (IMI) information day
17/01/2020, 10:00 - 16:00
The upcoming IMI2 information day aims to bring together representatives and key figures from research and business area in Bulgaria and SEE in order to boost application and participation of CE and SEE countries in different IMI calls and projects. The first of two planned events will be held on 17th of January 2020 in Sofia.
Along with the general information about IMI, a representative from the initiative will join the workshop and will present detailed information about the upcoming funding opportunities in 2020, as the focus will be on IMI2 – Call 20.
Participants will have the unique opportunity to exchange information and to share ideas, experience and good practices from the field, searching for the answer of the question “How could Bulgaria be successful in the upcoming IMI calls?”.
The access is freе!
Draft agenda
| 09:30 – 10:15 | Registration |
| 10:15 – 10:30 | Welcome and Opening Ministry of Education and Science – TBC Ministry of Health – TBC Prof. Victoria Sarafian, IMI States Representatives Group, Bulgaria |
| 10:30 – 11:00 | About IMI – introduction and general information Hugh Laverty, Head of Science Operations |
| 11:00 – 11:30 | EFPIA: pharmaceutical industry and IMI – TBC EFPIA representative |
| 11:30 – 11:45 | IMI in numbers: Statistics and Factsheet Hugh Laverty, Head of Science Operations |
| 11:45 – 12:00 | IMI2: Success stories Hugh Laverty, Head of Science Operations |
| 12:00 – 13:00 | Networking Lunch |
| 13:00 – 13:30 | IMI2: Application process – overview (procedures, tips, etc,) Hugh Laverty, Head of Science Operations |
| 13:30 – 14:00 | IMI2 funding opportunities, 2020: IMI2 – Call 20 Hugh Laverty, Head of Science Operations |
| 14:30 – 15:00 | H2020 and Bulgaria: results, potential and perspectives |
| 15:00 – 15:30 | Research and Business: is effective collaboration in Bulgaria possible? |
| 15:30 – 16:00 | Discussion: How can Bulgaria be successful in IMI2? |
| 16:00 | Closing Remarks |
[ecgf_form]
